Ped‐mTNS
In the 70 participants of whom ped‐mTNS data were available (≥5 years old and 35 in each randomization group), respectively, 72.7 and 64.9% in the push and one‐hour groups developed VIPN. The median number of follow‐up measurements was four in the push group (IQR 2.25–4.75) and three in the one‐hour group (IQR 1.5–5). The development of VIPN over time according to the ped‐mTNS was not significantly different between the randomization groups, both in the crude and adjusted analyses (Table Age, sex, concurrent azoles, diagnosis, and racial background were not identified as modifiers in the relationship between VIPN according to ped‐mTNS and randomization group.The results were similar in the per protocol analyses (data not shown).